Table 1.
Characteristics of the Study Group
| Parameter | n (%) |
|---|---|
| Age | |
| <60 | 5 (16.7%) |
| >60 | 25 (83.3%) |
| Sex | |
| Male | 16 (53.3%) |
| Female | 14 (46.7%) |
| Location | |
| Left-side | 14 (46.7%) |
| Right-side | 16 (53.3%) |
| Tumour’s size | |
| <3cm | 5 (16.7%) |
| >3cm | 25 (83.3%) |
| Histological type | |
| Adenocarcinoma | 25 (83.3%) |
| Mucinous adenocarcinoma | 5 (16.7%) |
| Depth of tumour invasion (pT) | |
| T2 | 10 (33.3%) |
| T3 | 20 (66.7%) |
| Lymph node metastasis (pN) | |
| N0 | 18 (60.0%) |
| N1+N2 | 12 (40.0%) |
| Distant metastasis (pM) | |
| M0 | 26 (86.7%) |
| M1 | 4 (13.3%) |
| Stage at diagnosis | |
| I | 8 (26.7%) |
| II | 8 (26.7%) |
| III | 10 (33.3%) |
| IV | 4 (13.3%) |
| Vascular invasion | |
| Absent | 12 (40.0%) |
| Present | 18 (60.0%) |
| Neural invasion | |
| Absent | 22 (73.3%) |
| Present | 8 (26.7%) |
| Inflammatory infiltration in the invasive front | |
| Absent and weak | 15 (50.0%) |
| Moderate and strong | 15 (50.0%) |
| Inflammatory infiltration in the tumour center | |
| Absent and weak | 16 (53.3%) |
| Moderate and strong | 14 (46.7%) |
| Tumour budding (TB) | |
| Bd1 | 13 (43.3%) |
| Bd2 | 8 (26.7%) |
| Bd3 | 9 (30.0%) |
| Poorly differentiated clusters (PDC) | |
| G1 | 30 (100.0%) |
| G2 | 0 (0.0%) |
| G3 | 0 (0.0%) |
| Areas of poorly differentiated components (APDC) | |
| G1 | 30 (100.0%) |
| G2 | 0 (0.0%) |